Abcam plc IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Abcam plc | ABCM - NASDAQ |
$16.52-$16.52 | $17.50 | $18.00 | 8.95 million ADSs | 10/22/2020 |
| Morgan Stanley, BofA Securities, SVB Leerink | ||||||
Co-Manager(s): Lazard, William Blair | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-10-02 Terms Added 2020-10-19 | ||||||
Abcam plc Quote & Chart - Click for current quote - ABCM
IPO Boutique aggregates information on public companies and private companies, such as "ABCM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Abcam plc (adapted from Abcam plc prospectus):
They are a global life science company focused on identifying, developing and distributing high-quality reagents and tools for our customers at the forefront of life science research. Their ordinary shares trade on AIM, a market of the London Stock Exchange, under the symbol “ABC.â€
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a global life science company focused on identifying, developing and distributing high-quality reagents and tools for our customers at the forefront of life science research. Their ordinary shares trade on AIM, a market of the London Stock Exchange, under the symbol “ABC.â€
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "ABCM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.